Amgen (AMGN)

What Happened? Shares of biotech company Amgen (NASDAQ:AMGN) jumped 3.1% in the afternoon session after the company received a favorable court ruling that bl...

Alphabet is a great company, but its dividend payout is underwhelming.

It may not duplicate those impressive results, but it has all the tools it needs.

Honeywell's spin-off was the catalyst for replacing Verizon with Alphabet in the Dow Jones Industrial Average.

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advanceme...

Weigh the financial strength of a pharma leader against the rapid growth, and risks, of a biotech newcomer as both navigate industry headwinds.

The iShares Nasdaq Biotechnology ETF (IBB) is trading just 1.47% below its 52-week high, signaling a potential multi-year sector breakout.

They look well-positioned to grab a slice of the fast-growing anti-obesity market.

Amgen posts strong profits and cash flow, while NovoCure pursues growth with a direct-to-patient cancer therapy model and leaner balance sheet.